Arcadia Biosciences (RKDA) Expected to Release Earnings on Wednesday

Arcadia Biosciences (NASDAQ:RKDA) is anticipated to issue its Q2 2026 results before the market opens on Wednesday, August 19th. Analysts expect Arcadia Biosciences to post earnings of ($0.56) per share and revenue of $1.90 million for the quarter. Parties can find conference call details on the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, August 20, 2026 at 4:00 PM ET.

Arcadia Biosciences (NASDAQ:RKDA) last released its quarterly earnings data on Thursday, May 14th. The basic materials company reported ($2.11) EPS for the quarter, missing the consensus estimate of ($0.80) by ($1.31). The business had revenue of $1.10 million during the quarter, compared to the consensus estimate of $1.60 million. Arcadia Biosciences had a negative return on equity of 113.73% and a negative net margin of 195.94%.

Arcadia Biosciences Trading Up 2.7%

Shares of RKDA opened at $0.67 on Wednesday. The firm has a fifty day simple moving average of $0.74 and a two-hundred day simple moving average of $1.23. The firm has a market cap of $1.61 million, a PE ratio of -0.12 and a beta of 0.56. Arcadia Biosciences has a 1-year low of $0.59 and a 1-year high of $6.71.

Wall Street Analyst Weigh In

Separately, Weiss Ratings downgraded Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, June 25th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.